echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Biochemistry News > Biotechnology News > Immunity: a new treatment for tuberculosis

    Immunity: a new treatment for tuberculosis

    • Last Update: 2021-07-31
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

     


    Image: Neutrophil extracellular traps (NETs) are released when white blood cells (neutrophils) are infected with Mycobacterium tuberculosis, which is the bacterium that causes tuberculosis


    Enhancing the body's own immune pathways against disease may provide answers to the urgent search for new treatments for tuberculosis


    Tuberculosis is still a huge global disease burden and one of the top ten causes of death in the world


    The research was led by Dr.


    • Researchers were able to prove that cells infected with tuberculosis bacteria have a functional apoptotic cell death pathway and showed their importance in fighting serious diseases


    • Using preclinical models, researchers were able to identify key apoptotic pathways as targets for new therapies, through which drugs called IAP inhibitors can kill infected cells


    • The study shows that host-directed therapy is feasible for infections such as tuberculosis, which is very important in the era of widespread antibiotic resistance



    Fighting antibiotic resistance

    Tuberculosis is caused by bacteria that infect the lungs and spreads from person to person through the air


    Tuberculosis bacteria grow in the immune cells of the lungs


    Using preclinical models, the researchers sequentially deleted key apoptotic effectors to prove their role in controlling tuberculosis infection


    Use host-directed therapy to reduce disease burden

    Dr.


    "When we treated our infection model with this compound, we were able to significantly reduce the number of tuberculosis," he said


    "The longer the treatment, the greater the reduction in disease


    The research team was able to replicate these results using different IAP inhibitors


    "It is exciting that many of these compounds are already in clinical trials for other types of diseases and have been shown to be safe and well tolerated by patients," said Dr.
    Stutz
    .

    "We predict that if these compounds make progress in the treatment of tuberculosis, they will be the most effective if used with existing antibiotic therapies
    .

    Opened the door to new treatments

    Professor Mark Pellegrini said that so far, antibiotics are the only way to treat tuberculosis, but due to the increase in antibiotic resistance, the application of antibiotics has been restricted
    .

    "Unlike antibiotics that directly kill bacteria, IAP inhibitors kill the cells that tuberculosis bacteria need to survive," he said
    .

    "The beauty of using host-directed therapy is that it does not directly target the microorganisms, but the host process
    .
    By targeting the host instead of the microorganisms, the chance of drug resistance is very low
    .
    "

    The team hopes that this research will lead to better treatments for tuberculosis
    .

    "This research increases our understanding of the types of immune responses that benefit us.
    This is an important step towards new treatments for tuberculosis.
    In the past 40 years, few new treatments have been developed," Dr.
    Stutz Say
    .

    "We have proven that host-directed therapy for infections such as tuberculosis is feasible, which is especially important in the era of widespread antibiotic resistance
    .
    "


    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.